Blood Clotting and Platelet Function: Study Notes

Blood: Hemostasis and Platelet Function

Introduction to Hemostasis

Hemostasis is the physiological process that stops bleeding at the site of an injury while maintaining normal blood flow elsewhere in the circulation. It involves a complex interplay between blood vessels, platelets, and plasma proteins.

• Hemostasis consists of three main phases: vascular spasm, platelet plug formation, and coagulation (clotting).

• Disorders of hemostasis can lead to excessive bleeding or unwanted clot formation (thrombosis).

Phases of Hemostasis

• Vascular Spasm: Immediate vasoconstriction of damaged blood vessels to reduce blood flow and loss.

• Platelet Plug Formation: Platelets adhere to exposed collagen fibers at the injury site, become activated, and aggregate to form a temporary plug.

• Coagulation (Clotting): A cascade of enzymatic reactions leads to the conversion of fibrinogen to fibrin, stabilizing the platelet plug into a firm clot.

Platelets (Thrombocytes)

Platelets are small, anucleate cell fragments derived from megakaryocytes in the bone marrow. They play a central role in hemostasis.

• Normal Platelet Count: 150,000–400,000 per microliter of blood.

• Functions:

  • Adhere to damaged endothelium and exposed collagen.

  • Release chemical mediators (e.g., ADP, thromboxane A2) that recruit more platelets.

  • Provide a surface for coagulation factor activation.

Platelet Plug Formation

• Adhesion: Platelets stick to exposed collagen at the injury site, mediated by von Willebrand factor.

• Activation: Platelets change shape, release granule contents (ADP, serotonin, thromboxane A2), and express surface receptors.

• Aggregation: Platelets stick to each other, forming a plug that temporarily seals small vessel breaks.

Coagulation Cascade

The coagulation cascade is a series of enzymatic reactions that culminate in the formation of a stable fibrin clot.

• Involves intrinsic and extrinsic pathways, both leading to a common pathway.

• Key step: Conversion of prothrombin to thrombin, which then converts fibrinogen to fibrin.

Key Equations:

• $\text{Prothrombin} \xrightarrow{\text{Thrombinase}} \text{Thrombin}$

• $\text{Fibrinogen} \xrightarrow{\text{Thrombin}} \text{Fibrin}$

Antiplatelet Agents and Clot Prevention

• Aspirin: Inhibits cyclooxygenase, reducing thromboxane A2 production and thus platelet aggregation.

• Other agents: Clopidogrel, ticlopidine, and others inhibit platelet activation or aggregation by different mechanisms.

Clinical Application: Antiplatelet drugs are used to prevent arterial thrombosis in conditions such as myocardial infarction and stroke.

Clot Retraction and Fibrinolysis

• Clot Retraction: Platelets contract, pulling on fibrin threads and drawing the edges of the wound together.

• Fibrinolysis: The process by which the clot is dissolved after healing, primarily through the action of plasmin.

Key Equation:

• $\text{Plasminogen} \xrightarrow{\text{tPA}} \text{Plasmin}$

Summary Table: Phases and Key Components of Hemostasis

Phase	Main Event	Key Components
Vascular Spasm	Vasoconstriction	Vascular smooth muscle
Platelet Plug Formation	Platelet adhesion, activation, aggregation	Platelets, von Willebrand factor, ADP, thromboxane A2
Coagulation	Fibrin clot formation	Clotting factors, thrombin, fibrinogen
Clot Retraction	Clot contracts	Platelets, actin, myosin
Fibrinolysis	Clot dissolution	Plasminogen, plasmin, tPA

Additional info:

• Some terms and details were inferred based on standard A&P content, as the original notes were fragmented and partially illegible.

• For a more comprehensive understanding, refer to Chapter 17 (Blood) and related chapters in your A&P textbook.